Original Research

Published on 31 May 2023

Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo

in Pharmacology of Anti-Cancer Drugs

Bharathi M. Rajamani
Raveen Stephen Stallon Illangeswaran
Esther Sathya Bama Benjamin
Balaji Balakrishnan
Daniel Zechariah Paul Jebanesan
Saswati Das
Aswin Anand Pai
Rakhi Thalayattu Vidhyadharan
Ajith Mohan
Sreeja Karathedath

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1187066

2,348 views
4 citations

Original Research

Published on 31 May 2023

Computational and experimental pharmacology to decode the efficacy of Theobroma cacao L. against doxorubicin-induced organ toxicity in EAC-mediated solid tumor-induced mice

in Pharmacology of Anti-Cancer Drugs

Priyanka P. Patil
Pranjal Kumar
Pukar Khanal
Vishal S. Patil
Harish R. Darasaguppe
Vishwambhar Vishnu Bhandare
Arati Bhatkande
Sudhanshu Shukla
Rajesh K. Joshi
Basanagouda M. Patil

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1174867

2,113 views
4 citations

Original Research

Published on 31 May 2023

Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible factor-1α

in Pharmacology of Anti-Cancer Drugs

Zhanxue Zhao
Linxun Liu
Hekai Chen
Shuai Li
Yan Guo
Xiaofan Hou
Jinyu Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1138265

2,118 views
1 citation

Original Research

Published on 30 May 2023

Acute osimertinib exposure induces electrocardiac changes by synchronously inhibiting the currents of cardiac ion channels

in Pharmacology of Anti-Cancer Drugs

Peiwen Li
Xiaohui Tian
Gongxin Wang
Enshe Jiang
Yanming Li
Guoliang Hao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1177003

2,393 views
2 citations

Hypothesis and Theory

Published on 30 May 2023

Will EGFRvIII and neuronal-derived EGFR be targets for imipramine?

in Pharmacology of Anti-Cancer Drugs

Zesheng Li
Bo Wang
Jianjian Wu
Lei Han

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1156492

1,669 views

Systematic Review

Published on 30 May 2023

Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma

in Pharmacology of Anti-Cancer Drugs

Yang Zheng
Heling Peng
Xu Hu
Yong Ou
Dong Wang
Han Wang
Shangqing Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1199395

2,401 views
2 citations

Review

Published on 30 May 2023

RIPK2: a promising target for cancer treatment

in Pharmacology of Anti-Cancer Drugs

Jieqiong You
Ying Wang
Haifeng Chen
Fang Jin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192970

5,948 views
5 citations

Original Research

Published on 26 May 2023

Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cells

in Pharmacology of Anti-Cancer Drugs

Paola Pacelli
Adele Santoni
Anna Sicuranza
Elisabetta Abruzzese
Valentina Giai
Monica Crugnola
Mario Annunziata
Sara Galimberti
Alessandra Iurlo
Luigiana Luciano

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1194712

2,241 views
2 citations

Systematic Review

Published on 25 May 2023

The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials

in Pharmacology of Anti-Cancer Drugs

Jingyue Qiu
Dandan Sheng
Fei Lin
Peng Jiang
Ning Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1157251

3,485 views
3 citations

Original Research

Published on 25 May 2023

Black tea bioactive phytoconstituents realign NRF2 for anticancer activity in lung adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Suchisnigdha Datta
Anupam Bishayee
Dona Sinha

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1176819

4,857 views

Review

Published on 24 May 2023

The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Dongming Li
Donghui Cao
Yingnan Cui
Yuanlin Sun
Jing Jiang
Xueyuan Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1201085

3,253 views
3 citations

Review

Published on 24 May 2023

Nanoparticles as drug delivery systems in the treatment of oral squamous cell carcinoma: current status and recent progression

in Pharmacology of Anti-Cancer Drugs

Shuxia Cui
Hanzhe Liu
Guanglin Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1176422

3,542 views
4 citations

Original Research

Published on 23 May 2023

A novel benzothiazole derivative induces apoptosis via the mitochondrial intrinsic pathway producing antitumor activity in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Jing Zhou
Rongce Zhao
Haoxuan Zhou
Shuping Yang
Feiyan Tao
Yongmei Xie
Hongli Wang
Jingping Yun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1196158

1,592 views
4 citations

Case Report

Published on 23 May 2023

Ripretinib in combination with tyrosine kinase inhibitor as a late-line treatment option for refractory gastrointestinal stromal tumors: two case reports and literature review

in Pharmacology of Anti-Cancer Drugs

Yefan Zhang
Zhen Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1122885

2,002 views
1 citation

Original Research

Published on 22 May 2023

Development of a novel copper metabolism-related risk model to predict prognosis and tumor microenvironment of patients with stomach adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Dongjie Sun
Haiying Zhang
Chi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1185418

1,873 views
1 citation

Systematic Review

Published on 22 May 2023

Association between immune-related adverse events and immunotherapy efficacy in non-small-cell lung cancer: a meta-analysis

in Pharmacology of Anti-Cancer Drugs

Li Lin
Yu Liu
Chen Chen
Anhua Wei
Wei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1190001

3,053 views
9 citations

Navigation group

Articles

Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo

Computational and experimental pharmacology to decode the efficacy of Theobroma cacao L. against doxorubicin-induced organ toxicity in EAC-mediated solid tumor-induced mice

Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible factor-1α

Acute osimertinib exposure induces electrocardiac changes by synchronously inhibiting the currents of cardiac ion channels

Will EGFRvIII and neuronal-derived EGFR be targets for imipramine?

Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma

RIPK2: a promising target for cancer treatment

Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cells

The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials

Black tea bioactive phytoconstituents realign NRF2 for anticancer activity in lung adenocarcinoma

The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma

Nanoparticles as drug delivery systems in the treatment of oral squamous cell carcinoma: current status and recent progression

A novel benzothiazole derivative induces apoptosis via the mitochondrial intrinsic pathway producing antitumor activity in colorectal cancer

Ripretinib in combination with tyrosine kinase inhibitor as a late-line treatment option for refractory gastrointestinal stromal tumors: two case reports and literature review

Development of a novel copper metabolism-related risk model to predict prognosis and tumor microenvironment of patients with stomach adenocarcinoma

Association between immune-related adverse events and immunotherapy efficacy in non-small-cell lung cancer: a meta-analysis